The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Lyons, Emer
    Director born in January 1978
    Individual (10 offsprings)
    Officer
    2023-10-12 ~ now
    OF - Director → CIF 0
  • 2
    Hollywood, Simon
    Solicitor born in January 1980
    Individual (4 offsprings)
    Officer
    2023-10-12 ~ now
    OF - Director → CIF 0
  • 3
    Fox, Erina
    Individual (27 offsprings)
    Officer
    2020-01-22 ~ now
    OF - Secretary → CIF 0
  • 4
    MEDPASS GROUP LIMITED - 2021-04-19
    500, South Oak Way, Green Park, Reading, Berkshire, United Kingdom
    Active Corporate (4 parents, 2 offsprings)
    Equity (Company account)
    32,145,059 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
Ceased 9
  • 1
    Vander Velde, Christian
    Consultant born in November 1952
    Individual
    Officer
    1998-09-08 ~ 2000-01-10
    OF - Director → CIF 0
  • 2
    Sorrel, Sarah Anne
    Company Director born in September 1957
    Individual
    Officer
    1998-09-08 ~ 2021-04-08
    OF - Director → CIF 0
  • 3
    Harte, Brendan
    Director born in May 1965
    Individual
    Officer
    2020-01-22 ~ 2023-10-12
    OF - Director → CIF 0
  • 4
    Baran, Wasyl
    Consultant born in June 1958
    Individual
    Officer
    1998-09-08 ~ 2000-01-10
    OF - Director → CIF 0
    Baran, Wasyl
    Individual
    Officer
    1998-09-08 ~ 2009-12-31
    OF - Secretary → CIF 0
  • 5
    O'boyle, Bryan
    Director born in October 1982
    Individual
    Officer
    2020-01-22 ~ 2023-10-12
    OF - Director → CIF 0
  • 6
    Mckeown, Thomas
    Consultant born in January 1947
    Individual
    Officer
    1998-09-08 ~ 2000-01-10
    OF - Director → CIF 0
  • 7
    Sorrell Dejerine, Eirc
    Medical Doctor born in May 1956
    Individual
    Officer
    1998-09-08 ~ 2000-01-10
    OF - Director → CIF 0
  • 8
    Gleeson, Michael
    Director born in November 1978
    Individual (9 offsprings)
    Officer
    2020-01-22 ~ 2022-10-21
    OF - Director → CIF 0
  • 9
    72 New Bond Street, London
    Dissolved Corporate (1 parent, 211 offsprings)
    Equity (Company account)
    2 GBP2022-12-31
    Officer
    1998-09-08 ~ 1998-09-08
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

ICON CLINICAL RESEARCH (U.K.) NO. 4 LIMITED

Previous name
MEDPASS INTERNATIONAL LIMITED - 2021-04-19
Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Turnover/Revenue
117,294 GBP2021-01-01 ~ 2021-12-31
Gross Profit/Loss
117,294 GBP2021-01-01 ~ 2021-12-31
Administrative Expenses
-7,165 GBP2022-01-01 ~ 2022-12-31
-81,533 GBP2021-01-01 ~ 2021-12-31
Distribution Costs
264,545 GBP2022-01-01 ~ 2022-12-31
-43,733 GBP2021-01-01 ~ 2021-12-31
Operating Profit/Loss
257,380 GBP2022-01-01 ~ 2022-12-31
-7,972 GBP2021-01-01 ~ 2021-12-31
Other Interest Receivable/Similar Income (Finance Income)
16,410 GBP2022-01-01 ~ 2022-12-31
2,975 GBP2021-01-01 ~ 2021-12-31
Profit/Loss on Ordinary Activities Before Tax
273,790 GBP2022-01-01 ~ 2022-12-31
5,161,241 GBP2021-01-01 ~ 2021-12-31
Profit/Loss
221,676 GBP2022-01-01 ~ 2022-12-31
5,162,077 GBP2021-01-01 ~ 2021-12-31
Debtors
5,817,704 GBP2022-12-31
5,551,002 GBP2021-12-31
Cash at bank and in hand
335 GBP2022-12-31
43,355 GBP2021-12-31
Current Assets
5,818,039 GBP2022-12-31
5,594,357 GBP2021-12-31
Net Current Assets/Liabilities
5,806,614 GBP2022-12-31
5,584,938 GBP2021-12-31
Net Assets/Liabilities
5,806,614 GBP2022-12-31
5,584,938 GBP2021-12-31
Equity
Called up share capital
100 GBP2022-12-31
100 GBP2021-12-31
100 GBP2020-12-31
Retained earnings (accumulated losses)
5,806,514 GBP2022-12-31
5,584,838 GBP2021-12-31
422,761 GBP2020-12-31
Equity
5,806,614 GBP2022-12-31
5,584,938 GBP2021-12-31
422,861 GBP2020-12-31
Profit/Loss
Retained earnings (accumulated losses)
221,676 GBP2022-01-01 ~ 2022-12-31
5,162,077 GBP2021-01-01 ~ 2021-12-31
Average Number of Employees
32022-01-01 ~ 2022-12-31
32021-01-01 ~ 2021-12-31
Audit Fees/Expenses
1,000 GBP2022-01-01 ~ 2022-12-31
1,500 GBP2021-01-01 ~ 2021-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
392 GBP2022-01-01 ~ 2022-12-31
-46 GBP2021-01-01 ~ 2021-12-31
Tax Expense/Credit at Applicable Tax Rate
52,020 GBP2022-01-01 ~ 2022-12-31
980,636 GBP2021-01-01 ~ 2021-12-31
Property, Plant & Equipment - Gross Cost
Tools/Equipment for furniture and fittings
384 GBP2022-12-31
2,697 GBP2021-12-31
Property, Plant & Equipment - Disposals
Tools/Equipment for furniture and fittings
-2,313 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Tools/Equipment for furniture and fittings
384 GBP2022-12-31
2,697 GBP2021-12-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Tools/Equipment for furniture and fittings
-2,313 GBP2022-01-01 ~ 2022-12-31
Amounts Owed By Related Parties
5,817,010 GBP2022-12-31
5,543,007 GBP2021-12-31
Other Debtors
284 GBP2022-12-31
6,189 GBP2021-12-31
Prepayments
410 GBP2022-12-31
Amount of corporation tax that is recoverable
1,414 GBP2021-12-31
Taxation/Social Security Payable
1,119 GBP2022-12-31
850 GBP2021-12-31
Par Value of Share
Class 2 ordinary share
12022-01-01 ~ 2022-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
70 shares2022-12-31
70 shares2021-12-31
Par Value of Share
Class 3 ordinary share
12022-01-01 ~ 2022-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
10 shares2022-12-31
10 shares2021-12-31
Par Value of Share
Class 4 ordinary share
12022-01-01 ~ 2022-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
10 shares2022-12-31
10 shares2021-12-31
Number of Shares Issued (Fully Paid)
100 shares2022-12-31
100 shares2021-12-31
  • ICON CLINICAL RESEARCH (U.K.) NO. 4 LIMITED
    Info
    MEDPASS INTERNATIONAL LIMITED - 2021-04-19
    Registered number 03628305
    1 More London Place, London SE1 2AF
    Private Limited Company incorporated on 1998-09-08 (27 years 1 month). The company status is Liquidation.
    The last date of confirmation statement was made at 2024-03-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.